Many states have floated world tenders for vaccines as doses for the 18 to 44 age group fall quick, however Bihar, dominated by BJP ally Nitish Kumar, has determined in opposition to it.
Bihar Health Minister Mangal Pandey indicated that the state is unlikely to go searching for world vaccines.
“See how other states floated global tenders and what the results were,” Mr Pandey instructed NDTV, when requested why Bihar had not floated any world tenders to purchase vaccines immediately.
“We received 1 crore 1 lakh vaccines. 98 lakh people have been vaccinated till Sunday,” the minister mentioned.
BJP-ruled Madhya Pradesh has reportedly additionally determined to not take that route, based on sources.
Several states introduced they’d attempt to purchase vaccines immediately from worldwide producers after the dearth of doses slowed down or halted vaccinations that had been opened to all adults on May 1.
So far, that course of has not produced any outcomes.
Vaccine-makers Pfizer and Moderna have mentioned as a matter of coverage they’ll cope with the centre as a substitute of states.
Moderna instructed the Punjab authorities that their coverage was to cope with the Government of India and never with any state authorities or personal events.
The Punjab authorities had approached for Sputnik V, Pfizer, Moderna and Johnson and Johnson, however solely Moderna responded, that too within the unfavorable.
Tamil Nadu and Andhra Pradesh have additionally floated tenders, however the response to Punjab’s makes an attempt signifies it’s largely a symbolic and fruitless transfer.
Others like Uttar Pradesh, Maharashtra, Karnataka and Telangana have additionally opted for world tenders.
Delhi Chief Minister Arvind Kejriwal wrote to Prime Minister Narendra Modi that as a substitute of leaving it to states, the Centre ought to import COVID-19 vaccines at a nationwide stage.
The Centre’s new coverage permits states and personal hospitals to purchase vaccines immediately from producers, who, nonetheless, say they’ll prioritise the central authorities and shouldn’t have the sources to fulfill the present nationwide demand.
India has been utilizing Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin to this point within the vaccination drive that started in January. Russia’s Sputnik will probably be third vaccine for use.